- Home
- VRTX vs MSTR Comparison
VRTX vs MSTR Comparison
Compare VRTX & MSTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRTX
- MSTR
- Stock Information
- Founded
- VRTX 1989
- MSTR 1989
- Country
- VRTX United States
- MSTR United States
- Employees
- VRTX N/A
- MSTR N/A
- Industry
- VRTX EDP Services
- MSTR Computer Software: Prepackaged Software
- Sector
- VRTX Technology
- MSTR Technology
- Exchange
- VRTX Nasdaq
- MSTR Nasdaq
- Market Cap
- VRTX 115.6B
- MSTR 106.8B
- IPO Year
- VRTX 1991
- MSTR 1998
- Fundamental
- Price
- VRTX $445.37
- MSTR $402.23
- Analyst Decision
- VRTX Buy
- MSTR Strong Buy
- Analyst Count
- VRTX 26
- MSTR 11
- Target Price
- VRTX $510.48
- MSTR $404.18
- AVG Volume (30 Days)
- VRTX 1.3M
- MSTR 10.3M
- Earning Date
- VRTX 07-31-2025
- MSTR 07-31-2025
- Dividend Yield
- VRTX N/A
- MSTR N/A
- EPS Growth
- VRTX N/A
- MSTR N/A
- EPS
- VRTX N/A
- MSTR N/A
- Revenue
- VRTX $11,099,700,000.00
- MSTR $459,276,000.00
- Revenue This Year
- VRTX $10.48
- MSTR $1.77
- Revenue Next Year
- VRTX $10.69
- MSTR $3.43
- P/E Ratio
- VRTX N/A
- MSTR N/A
- Revenue Growth
- VRTX 8.98
- MSTR N/A
- 52 Week Low
- VRTX $377.85
- MSTR $102.40
- 52 Week High
- VRTX $519.88
- MSTR $543.00
- Technical
- Relative Strength Index (RSI)
- VRTX 45.87
- MSTR 54.79
- Support Level
- VRTX $436.81
- MSTR $358.80
- Resistance Level
- VRTX $451.88
- MSTR $392.67
- Average True Range (ATR)
- VRTX 9.25
- MSTR 11.34
- MACD
- VRTX 0.32
- MSTR 0.39
- Stochastic Oscillator
- VRTX 28.02
- MSTR 79.91
About VRTX Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease. Additionally, Vertex is evaluating small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
About MSTR MicroStrategy Incorporated
Strategy is a bitcoin treasury company and a provider of business intelligence services. It is designed to provide investors varying degrees of economic exposure to Bitcoin by offering a range of securities, including equity and fixed-income instruments. The company also provide industry AI-powered enterprise analytics software.